Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

66

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

66 results for “PTA”

Learn how ShareScore rates datasets ↗
zenodo44/100

Comparing recent PTA results on the nanohertz stochastic gravitational wave background - full noise and GWB parameter comparison plots

<p>A full collection of plots comparing the noise properties of individual pulsars and gravitational wave background parameters discussed in the companion paper <em>Comparing recent PTA results on the nanohertz stochastic gravitational wave background</em> (IPTA 2024).</p> <p><code>Section4_GWB_comparison.zip</code> supplements and expands section 4.1, "Comparing the published GWB measurements," of IPTA (2024). It contains parameter difference distributions for GWB model parameters.&nbsp; There are four different models included. The HD correlated powerlaw (PL) model make up the basis for Figure 2.&nbsp; Additionally, there are three comparisons not included in IPTA (2024).&nbsp; First, comparisons the common uncorrelated red noise (CURN) PL model are included.&nbsp; Finally,&nbsp; comparisons of two free spectral (FS) models (HD and CURN) are included.&nbsp; These comparisons fit the HD and CURN FS posteriors using the <code>ceffyl</code> software package, and then compare the parameters of the resulting powerlaw fits.</p> <p><code>Section5_Noise_comparison.zip</code> supplements section 5, "Comparing Pulsar Noice Properties," of IPTA (2024).&nbsp; It contains plots for 27 pulsars timed by more than one PTA collaboration, including the plots for PSR J1012+5307, which are presented in Figure 7.&nbsp; The plots include noise parameter posteriors, time domain GP realizations, TOA residuals, and TOA radio frequency.</p>

opencc-by-4.0Apr 2024View details →
zenodo40/100

Micro-CT image of cell-populated collagen scaffold in the aqueous environment (contrasted with PTA)

<p>A dataset of the collagen scaffold populated with the 3T3 cells scanned in the aqueous environment using Bruker Skyscan 1276 machine (Bruker, Belgium).&nbsp;</p><p><strong>Scaffold production</strong></p><p>The processes of obtaining and working with collagen scaffolds were conducted in an isolated environment under sterile conditions. The collagen sponge matrix was manufactured at the Center for Collagen Innovation within the Institute of Regenerative Medicine at Sechenov University and provided to us for experimental purposes. In order to obtain the collagen, the authors utilized animal-derived materials sourced from the tendons of large horned cattle. To do this, the tendons were cleaned of excess tissues, cut into pieces with a thickness of 0.5-1 cm, and sequentially treated for 12 hours in a 0.5 M NaCl solution. Subsequently, the mass was homogenized in a 0.83 M acetic acid solution. The resulting suspension was hydrolyzed with 0.24% pepsin for 2 days, after which 1 M NaOH was added to adjust the pH to 7.5, halting the hydrolysis process. The suspension was precipitated with a 12% NaCl solution, the resulting precipitate was redissolved in 0.02 M acetic acid, and then dialyzed. To obtain collagen porous matrices (sponges), the obtained solution was neutralized using 0.1 M NaOH until a pH of 7-7.5 was reached, and the resulting suspension was lyophilized at -40°C for 2 days.</p><p>Subsequently, the collagen matrix was cut into cubes with sides measuring 0.5 cm. These cubes were placed in 15 ml test tubes filled with 70% ethyl alcohol for sterilization. The test tubes were then placed on a shaker and left in the refrigerator at +4°C for 24 hours. Afterward, the collagen matrices were removed from the alcohol and rinsed five times with 0.9% NaCl.</p><p>Following the alcohol rinse to confirm the absence of toxicity, an elution test, adapted following the ISO 10993 protocol, was conducted. To obtain collagen cube extracts, they were incubated in a cell culture medium at a volume of 1 ml per sample for 24 hours at 37°C. The 3T3 cell culture was passaged, with 5000 cells seeded in each well of a 96-well plate. After 24 hours, the cells were treated with extract at a volume of 200 µl per well and left in the incubator at 37°C for 24 hours. The following day, extracts were collected, and AlamarBlue reagent (Invitrogen, Waltham, MA, USA) was added according to the manufacturer's instructions to assess the metabolic activity of the cells. Serial dilutions of sodium dodecyl sulfate (SDS) were used as the positive control. Fluorescence intensity was measured using a Victor Nivo spectrofluorimeter (PerkinElmer, Waltham, Massachusetts, USA) at an excitation wavelength of 530 nm and an emission wavelength of 590 nm.</p><p><strong>Cell seeding</strong></p><p>After confirming the absence of cytotoxic effects, collagen sponges were seeded with the NIH 3T3 cell line at a density of 50,000 cells per sample (cubes of collagen sponge measuring 0.5 cm per side).&nbsp;</p><p><strong>Staining technique</strong></p><p>Fixed specimens in 10% formalin with PBS were washed after 24 hours with distilled water and after that placed in 3% phosphotungstic acid dissolved in distilled water for 24 hours and kept on the rotary shaker at room temperature. After staining, samples were washed and stored in distilled water at 5 °C.&nbsp;</p><p><strong>Image acquisition and reconstruction</strong></p><p>A plastic tube filled with distilled water containing the contrasted sample was placed on the sample holder in a SkyScan 1276 micro-CT (Bruker, Kontich, Belgium) and were scanned at 3 μm voxel resolution with 70 kV voltage and 200 uA source power and an aluminum filter with 1 mm of thickness. The rotation was set to 360° around the vertical axis of the sample, with two middle frames for each 0.2° angle step.</p><p>After scanning, the data were reconstructed using Bruker's NRecon software. During reconstruction, the ring artifact reduction value was set to 20% and the beam hardening correction value to 30%.&nbsp;After that, samples were exported as a series of 16-bit TIFF images which could be opened in the specialized software.&nbsp;</p>

opencc-by-4.0Nov 2023View details →
zenodo40/100

TEI-Schema für das Patristische Textarchiv (PTA)

This dataset contains the TEI-Schema and its documentation

opengpl-3.0Jun 2023View details →
zenodo40/100

Metadaten für das Patristische Textarchiv (PTA)

This dataset contains metadata and linked open data to the Patristic Text Archive (PTA)

opencc-by-sa-4.0Jul 2022View details →
ClinicalTrials.gov36/100

GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis

ClinicalTrials.gov study NCT00737672. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA

ClinicalTrials.gov study NCT02963649. IPD Sharing: NO. Countries: 5. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Study of IN.PACT Amphirion™ Drug Eluting Balloon vs. Standard PTA for the Treatment of Below the Knee Critical Limb Ischemia

ClinicalTrials.gov study NCT00941733. IPD Sharing: Not stated. Countries: 6. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Randomized Trial of IN.PACT Admiral® Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease

ClinicalTrials.gov study NCT01175850. IPD Sharing: Not stated. Countries: 1. Publications: 6.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

ClinicalTrials.gov study NCT03551496. IPD Sharing: NO. Countries: 5. Publications: 19.

closedIPD-NOFeb 2026View details →
zenodo32/100

Insertion sites sizes (FR) and phalangeal size (PTA)

<p>Data to replicate the results of the paper &quot;Insertion sites in manual proximal phalanges of African apes and modern humans. Looking for behavioral traces in phalanges&quot;</p> <p>&nbsp;</p> <p>The database includes the insertion sites sizes (mm<sup>2</sup>) for the A2 pulley in a sample of gorilla, chimpanzee and human hands. These areas in anthropology are called &quot;flexor ridges&quot; (FR). They were measured in 3D models of&nbsp;manual proximal phalanges 2-5 (PP2-PP5) &nbsp;It also includes the area (mm<sup>2</sup>) of the corresponding phalanges (PTA), the length of the first metacarpal of the corresponding hand (MC1_length) and the sex of the individuals, when known.&nbsp;</p> <p>&nbsp;</p> <p>Please cite:&nbsp;Bucchi, A., Luengo, J., Del Bove, A &amp; Lorenzo, C. (2020) Lorenzo. Insertion sites in manual proximal phalanges of African apes and modern humans. American Journal of Physical Anthropology 173(3), 556-567. doi: 10.1002/ajpa.24127.</p>

opencc-by-4.0Jul 2020View details →
ClinicalTrials.gov32/100

Clinical Use and Safety of the Xtreme Touch (Magic Touch PTA)- Neo Sirolimus Coated PTA Balloon Catheter in the Treatment of Infrainguinal Peripheral Arterial Disease

ClinicalTrials.gov study NCT04368091. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Treatment of Complex Femoropopliteal Artery Lesions Using Drug-coated PTA Balloon

ClinicalTrials.gov study NCT05616520. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

ClinicalTrials.gov study NCT00471289. IPD Sharing: Not stated. Countries: 1. Publications: 19.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

A Clinical Investigation of SM-01 Stenting Versus PTA for the Treatment of Superficial Femoral Artery Disease

ClinicalTrials.gov study NCT01183117. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

To Demonstrate That Lactobacillus Reuteri ATCC PTA 4659 Survives Passage Through the Gastrointestinal Tract of Humans

ClinicalTrials.gov study NCT01033539. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Supplementation With Lacobacillus Reuteri ATCC PTA 4659 in Patients Affected by Acute Uncomplicated Diverticulitis

ClinicalTrials.gov study NCT03656328. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

L. Reuteri ATCC PTA 5289 & L. Reuteri DSM 17938 for the Treatment of Children With Pharyngitis and/or Tonsillitis

ClinicalTrials.gov study NCT03377374. IPD Sharing: NO. Countries: 1. Publications: 5.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

The Effect of Lactobacillus Reuteri ATCC PTA 6475 on Volumetric Bone Mineral Density in Patients With Osteopenia

ClinicalTrials.gov study NCT02422082. IPD Sharing: NO. Countries: 1. Publications: 5.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

ClinicalTrials.gov study NCT06124586. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries

ClinicalTrials.gov study NCT02013193. IPD Sharing: NO. Countries: 3. Publications: 1.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record